The Future of SPL: What’s Next?

Explore the Possibilities of SPL
Structured Product Labeling (SPL) initially focused solely on human
prescription drugs and has proven to be a broadly adaptable standard.
Join industry, vendors, and the standards community to share ideas
and explore the future possibilities and downstream uses of SPL.

FEATURED TOPICS
• Possible Uses of SPL in REMS (Risk Evaluation and Mitigation Strategy)
• SPL and Clinical Decision Support Systems
• SPL at NLM (National Library of Medicine) – DailyMed
• SPL Use Inside the Pharmaceutical Industry
• SPL and Global Labeling: What’s Missing?
• SPL: Thinking outside the box – Next steps
• SPL & IDMP (Identification of Medicinal Products)

EVENT INFORMATION
Contact Colleen Braun, Meeting Manager, Phone +1.215.442.6160
Fax +1.215.442.6199, email Colleen.Braun@diahome.org

TABLETOP EXHIBIT INFORMATION
Attendees may visit the tabletop exhibits during the event and receptions.
Contact Shannon Lewis, Exhibits Associate, Phone +1.215.442.6149
Fax +1.215.442.6199, email Shannon.Lewis@diahome.org